We also welcome OSR's ... We will ensure you are kept updated as this work advances, and we remain committed to maintaining open, constructive and transparent engagement with OSR throughout this period.
I want to take this opportunity to reaffirm that the fundamentals of OSR Holdings, Inc ... We view this potential licensing transaction as a meaningful validation of VXM01's platform value and of OSR Holdings' hub-and-spoke biotech strategy.
12, 2026 /PRNewswire/ -- OSR Holdings, Inc ... The fairness opinion will evaluate whether the proposed transaction is fair and reasonable to Vaximm and OSR Holdings' shareholders from a financial point of view, based on the fair market value of VXM01.
Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S.FDA trial with a leading California research university ....